immun
jane
e
syke
w
key
point
activ
immun
partial
complet
protect
dog
cat
sever
consequ
infect
varieti
differ
pathogen
case
reduc
shed
pathogen
vaccin
contain
attenu
live
microorgan
inactiv
microorgan
portion
organ
also
contain
preserv
adjuv
failur
immun
occur
improp
storag
administr
vaccin
larg
challeng
dose
host
factor
concurr
infect
diseas
interfer
matern
antibodi
advers
effect
vaccin
administr
uncommon
rare
includ
hypersensit
reaction
diseas
induc
live
attenu
vaccin
organ
injectionsit
sarcoma
cat
decis
administ
vaccin
base
discuss
risk
benefit
veterinarian
pet
owner
document
medic
record
guidelin
vaccin
select
administr
publish
number
veterinari
bodi
aafp
aaha
avma
wsava
suggest
also
found
appendix
immun
refer
artifici
induct
immun
protect
infecti
diseas
may
activ
passiv
activ
immun
involv
administr
vaccin
stimul
cellmedi
humor
immun
specif
pathogen
passiv
immun
refer
administr
antibodi
order
provid
temporari
protect
diseas
occur
acquisit
matern
deriv
antibodi
mda
transplacent
colostrum
milk
treatment
prepar
contain
specif
nonspecif
immunoglobulin
see
immunomodul
chapter
postexposur
prophylaxi
rabi
chapter
reader
refer
advanc
immunolog
text
detail
descript
physiolog
activ
passiv
immun
goal
immun
gener
protect
immun
respons
prolong
durat
specif
infecti
diseas
minim
advers
effect
potenti
advers
effect
vaccin
perform
risk
signific
morbid
mortal
infecti
diseas
sinc
huge
number
vaccin
dog
cat
develop
market
worldwid
develop
nevertheless
estim
even
develop
countri
unit
state
dog
properli
immun
possibl
even
smaller
proport
cat
appropri
vaccin
larger
proport
pet
popul
may
assist
reduct
preval
infecti
diseas
induct
herd
immun
appear
injectionsit
sarcoma
cat
increas
emphasi
place
vaccin
safeti
chang
annual
immun
protocol
vaccin
recommend
administr
vaccin
base
exposur
risk
vaccin
profound
influenc
control
infecti
diseas
mani
vaccin
benefit
vaccin
outweigh
risk
vaccin
suspens
attenu
live
inactiv
microorgan
part
thereof
administ
induc
immun
addit
protect
antigen
vaccin
may
contain
preserv
stabil
well
specif
antibiot
preserv
antigen
inhibit
bacteri
fungal
growth
within
vaccin
vaccin
also
contain
adjuv
enhanc
immun
respons
antigen
although
mechan
complet
clear
adjuv
delay
releas
antigen
site
inject
induc
secret
chemokin
leukocyt
wide
use
adjuv
particul
adjuv
contain
aluminum
salt
precipit
aluminum
hydroxid
particul
adjuv
includ
immunostimul
saponin
present
canin
leishmania
vaccin
attenu
live
vaccin
modifi
live
vaccin
contain
microorgan
artifici
manipul
negat
greatli
reduc
virul
field
strain
low
virul
repeat
passag
cell
cultur
common
mean
attenu
replic
host
organ
attenu
live
vaccin
usual
stimul
immun
respons
close
mimic
protect
result
natur
infect
vaccin
attenu
live
canin
parvoviru
cpv
canin
distemp
viru
cdv
vaccin
absenc
mda
result
protect
immun
respons
within
day
singl
inject
may
follow
immun
last
mani
year
life
partial
immun
vaccin
attenu
live
cdv
felin
panleukopenia
viru
fpv
vaccin
occur
within
hour
addit
vaccin
organ
shed
serv
immun
anim
popul
howev
potenti
revers
virul
vaccineinduc
diseas
exist
vaccineinduc
diseas
like
occur
highli
immunosuppress
anim
attenu
live
vaccin
also
potenti
caus
immunosuppress
right
may
shift
balanc
immun
respons
rare
lead
clinic
diseas
exampl
outbreak
salmonellosi
report
cat
use
hightit
attenu
live
fpv
vaccin
rare
contamin
attenu
live
vaccin
occur
pathogen
microorgan
present
within
cell
cultur
use
propag
vaccin
gener
speak
inactiv
vaccin
less
effect
attenu
vaccin
replic
host
occur
produc
weaker
immun
respons
shorter
durat
frequent
booster
immun
may
requir
two
initi
dose
vaccin
week
apart
essenti
produc
effect
immun
respons
week
elaps
dose
recommend
seri
repeat
beyond
initi
vaccin
seri
clear
whether
laps
annual
booster
requir
seri
restart
consid
necessari
human
immun
suggest
dog
year
elaps
booster
inactiv
vaccin
usual
contain
adjuv
well
larg
infecti
dose
improv
immunogen
safer
live
attenu
vaccin
use
pregnanc
young
debilit
anim
although
bacterin
tradit
associ
greater
likelihood
allerg
reaction
live
attenu
vaccin
newer
inactiv
vaccin
safer
reaction
rate
close
approach
live
attenu
vaccin
maximum
durat
immun
induc
commerci
avail
bacterin
dog
cat
remain
larg
unknown
partli
challeng
studi
evalu
longterm
durat
immun
prohibit
expens
howev
inactiv
viral
vaccin
shown
durat
immun
excess
year
cat
caution
requir
extrapol
made
durat
immun
one
product
similar
product
differ
manufactur
may
equival
although
bacterin
usual
protect
anim
infect
may
prevent
clinic
ill
case
natur
infect
vaccin
anim
serv
boost
immun
respons
influenc
durat
immun
field
advantag
disadvantag
attenu
live
inactiv
vaccin
shown
tabl
subunit
vaccin
contain
specif
structur
compon
microb
stimul
protect
immun
respons
togeth
adjuv
contain
reduc
amount
foreign
protein
minim
potenti
hypersensit
reaction
recombin
dna
vaccin
creat
manipul
dna
pathogen
laboratori
negat
pathogen
virul
sometim
also
allow
diagnost
test
differenti
natur
infect
vaccin
anim
diva
differ
antibodi
respons
evok
vaccin
sever
differ
type
recombin
dna
vaccin
recombin
subunit
vaccin
produc
clone
one
gene
protect
antigen
express
vector
escherichia
coli
protein
express
bacteria
purifi
use
vaccin
figur
exampl
recombin
subunit
vaccin
lyme
recombin
ospa
vaccin
delet
mutant
vaccin
produc
delet
virul
gene
pathogen
protect
antigen
left
place
current
vaccin
dog
cat
vector
vaccin
produc
insert
gene
one
protect
antigen
genom
viru
viru
replic
host
express
antigen
nonpathogen
see
figur
b
current
avail
vector
vaccin
dog
cat
use
canarypox
viru
vector
dna
vaccin
consist
nake
dna
encod
antigen
requir
protect
immun
dna
inject
directli
anim
use
inocul
system
dna
taken
host
cell
translat
antigen
humor
cellmedi
immun
respons
produc
dna
vaccin
current
avail
commerci
use
dog
cat
vaccin
store
administ
accord
label
recommend
inactiv
vaccin
occur
inadvert
frozen
heat
excess
temperatur
expos
excess
amount
light
use
beyond
expir
date
hand
wash
prepar
administr
vaccin
lyophil
product
reconstitut
proper
diluent
differ
vaccin
mix
syring
vial
reconstitut
product
use
immedi
recommend
attenu
live
vaccin
discard
hour
laps
sinc
reconstitut
although
publish
report
exist
viabil
vaccin
organ
time
reconstitut
abil
store
reconstitut
vaccin
elicit
immun
respons
vaccin
use
anim
speci
label
seriou
advers
effect
failur
immun
occur
vaccin
multipl
differ
pathogen
administ
simultan
inject
distant
site
possibl
combin
vaccin
use
simultan
vaccin
one
pathogen
appear
interfer
immun
respons
compon
vaccin
vaccin
manufactur
must
demonstr
protect
occur
specif
pathogen
vaccin
combin
product
equal
protect
occur
vaccin
pathogen
given
contrast
success
parenter
administr
differ
attenu
live
vaccin
day
interv
potenti
interfer
immun
respons
interv
week
prefer
human
patient
inactiv
vaccin
produc
interfer
way
possibl
administr
vaccin
anim
anesthesia
avoid
advers
reaction
may
difficult
imposs
recogn
situat
necessari
readminist
intranas
vaccin
anim
cough
sneez
administr
site
rout
administr
product
serial
number
expiri
date
individu
administ
vaccin
record
vaccin
administ
vaccin
vial
often
possess
adhes
label
easili
remov
appli
paper
medic
record
immun
respons
divid
innat
adapt
immun
respons
innat
immun
respons
nonspecif
act
immedi
line
defens
infect
compon
innat
immun
respons
consist
natur
killer
cell
recogn
host
cell
infect
virus
complement
activ
bacteri
cell
wall
compon
phagocyt
macrophag
dendrit
cell
adapt
immun
respons
develop
sever
day
involv
present
antigen
dendrit
cell
associ
major
histocompat
complex
stimul
b
cell
respons
togeth
b
vaccin
avail
dog
cat
induc
cellmedi
immun
cmi
induct
immunolog
memori
booster
effect
repeat
administr
although
presenc
antibodi
correl
protect
pathogen
cdv
cpv
lack
antibodi
infer
lack
protect
presenc
cmi
difficult
measur
vaccin
rare
protect
vaccin
individu
infect
diseas
particular
vaccin
canin
felin
respiratori
pathogen
prevent
diseas
reduc
preval
sever
diseas
well
reduc
number
organ
shed
limit
immun
follow
vaccin
especi
like
infect
immun
natur
infect
partial
shortliv
abil
vaccin
induc
immun
respons
depend
target
pathogen
vaccin
composit
rout
administr
also
host
factor
age
nutrit
pregnanc
statu
stress
concurr
infect
immun
statu
includ
presenc
absenc
passiv
acquir
antibodi
box
factor
may
also
influenc
vaccin
safeti
anim
particularli
dog
rottweil
breed
may
impair
abil
respond
vaccin
dog
term
nonrespond
situat
probabl
rare
efficaci
vaccin
use
booster
vaccin
administ
young
dog
less
year
age
significantli
reduc
respons
vaccin
rabi
viru
vaccin
compar
adult
dog
smallbre
dog
greater
serolog
respons
rabi
vaccin
largebre
dog
administr
vaccin
febril
anim
anim
moder
sever
ill
avoid
possibl
recoveri
occur
immun
respons
vaccin
may
suboptim
failur
immun
result
inadequ
dose
antigen
thu
divis
singl
vaccin
dose
administr
larger
number
dog
cat
smallbre
dog
oppos
largebre
dog
may
lead
failur
immun
veterinarian
split
vaccin
dose
shift
liabil
vaccin
manufactur
veterinarian
vaccin
failur
occur
immun
also
fail
face
overwhelm
challeng
dose
rout
administr
influenc
type
immun
respons
gener
subcutan
administr
associ
primarili
igg
respons
rare
induc
high
level
secretori
iga
antibodi
contrast
intranas
administr
result
iga
lesser
extent
igg
respons
immunogen
safeti
may
compromis
vaccin
administ
use
incorrect
rout
young
anim
mda
neutral
vaccin
antigen
interfer
effect
immun
one
common
reason
vaccin
failur
dog
cat
mda
titer
cpv
potenti
interfer
immun
amount
mda
puppi
kitten
one
point
time
predict
vari
depend
titer
dam
amount
colostrum
ingest
birth
result
seri
vaccin
administ
order
increas
chanc
success
immun
occur
soon
declin
mda
titer
suffici
low
concentr
figur
nevertheless
window
alway
exist
mda
concentr
high
enough
interfer
immun
suffici
prevent
natur
infect
window
known
window
suscept
window
vulner
use
recombin
vector
vaccin
overcom
interfer
mda
although
extent
appli
anim
passiv
immun
vector
viru
ie
immun
transfer
dam
immun
recombin
vector
vaccin
requir
clarif
replic
vector
abort
immun
respons
vector
may
reduc
result
passiv
transfer
neutral
antibodi
titer
vector
may
occur
mucos
vaccin
also
provid
greater
protect
face
mda
mucos
immun
system
matur
shortli
birth
whenev
possibl
anim
isol
suffici
time
elaps
proper
immun
parenter
mucos
vaccin
week
absolut
minimum
day
inocul
vaccin
failur
also
occur
anim
incub
diseas
vaccin
perform
time
vaccin
vaccin
rabi
cdv
cpv
fpv
presenc
circul
antibodi
correl
protect
tabl
thu
serolog
assay
use
dog
cat
decid
whether
vaccin
necessari
like
effect
serolog
assay
also
use
clear
pet
travel
although
test
measur
antibodi
respons
dog
cat
improv
recent
year
differ
laboratori
report
significantli
differ
valu
serum
target
pathogen
eg
respiratori
versu
system
pathogen
vaccin
composit
eg
inadequ
adjuv
rout
administr
young
age
breedgenet
factor
nutrit
pregnanc
statu
concurr
moder
sever
ill
fever
immunosuppress
drug
presenc
matern
antibodi
improp
vaccin
storag
administr
vaccin
attenu
live
viral
vaccin
within
last
day
week
inadequ
time
allow
immun
exposur
field
organ
box
specimen
lack
valid
sensit
specif
assay
sometim
use
assay
increas
cost
significantli
delay
immun
inpractic
assay
also
avail
detect
antibodi
respons
potenti
overcom
problem
associ
laboratori
qualiti
control
delay
immun
inpractic
assay
gener
quantit
although
high
antibodi
titer
gener
associ
greater
protect
anim
titer
may
still
resist
challeng
cmi
measur
convers
anim
titer
gener
regard
protect
potenti
develop
diseas
challeng
possibl
overwhelm
exposur
immun
suppress
measur
antibodi
titer
may
consid
anim
previou
advers
respons
vaccin
particularli
suscept
breed
eg
rottweil
cpv
infect
world
small
anim
veterinari
associ
wsava
suggest
puppi
could
test
least
week
final
puppi
vaccin
decid
whether
vaccin
cdv
cpv
necessari
neg
titer
prompt
addit
vaccin
puppi
rapid
inhous
serolog
assay
also
use
make
decis
regard
isol
euthanasia
shelter
situat
identif
immun
anim
unfortun
alway
possibl
know
posit
titer
repres
recent
infect
anim
test
posit
may
still
shed
viru
pose
risk
anim
young
puppi
kitten
posit
result
may
repres
persist
mda
presenc
activ
immun
mda
abil
protect
infect
inhous
serolog
assay
also
use
decid
whether
pregnant
anim
suscept
shelter
environ
thu
minim
advers
reaction
attenu
live
vaccin
group
anim
see
appendix
studi
evalu
perform
one
elisa
assay
synbiot
titerchek
cpvcpv
found
cpv
antibodi
sensit
specif
assay
respect
compar
hemagglutin
inhibit
cdv
respect
compar
serum
neutral
vaccin
need
infecti
diseas
caus
signific
morbid
mortal
vaccin
prevent
diseas
caus
order
produc
protect
immun
vaccin
must
stimul
reaction
anim
site
inject
system
may
caus
clinic
sign
ideal
sign
mild
either
unnotic
accept
pet
owner
rare
situat
advers
reaction
sever
enough
threaten
pet
life
sometim
enhanc
efficaci
lead
reduct
vaccin
safeti
veterinarian
encourag
report
advers
reaction
vaccin
technic
servic
veterinarian
employ
purpos
vaccin
manufactur
countri
drug
compani
report
detail
advers
reaction
drug
regulatori
author
understand
true
natur
incid
advers
effect
associ
vaccin
hamper
underreport
variabl
delay
vaccin
inconsist
appear
potenti
chronic
system
advers
effect
addit
correl
advers
reaction
vaccin
administr
young
anim
may
difficult
uniform
frequent
administr
vaccin
group
exampl
difficult
prove
connect
vaccin
distemp
develop
hypertroph
osteopathi
weimaran
dog
type
hypersensit
reaction
occur
allergen
crosslink
ige
molecul
bound
receptor
mast
cell
basophil
trigger
degranul
clinic
sign
type
hypersensit
respons
occur
vaccin
administr
includ
facial
periorbit
edema
urticaria
cutan
hyperemia
gener
pruritu
saliv
hypotens
shock
tachypnea
vomit
diarrhea
collaps
even
death
figur
vomit
respiratori
distress
common
cat
sign
gener
occur
within
hour
vaccin
administr
anaphylaxi
usual
begin
within
minut
estim
incid
anaphylaxi
vaccin
dog
cat
depend
vaccin
use
one
retrospect
studi
evalu
million
dog
nearli
million
cat
banfield
hospit
unit
state
studi
vaccineassoci
advers
effect
list
vaccin
reaction
allerg
reaction
anaphylaxi
urticaria
andor
cardiac
arrest
document
within
day
vaccin
administr
per
dog
per
cat
reaction
code
allerg
anaphylaxi
report
approxim
dog
cat
reaction
code
anaphylaxi
constitut
reaction
death
occur
dog
cat
receiv
vaccin
dog
cat
die
receiv
four
dose
vaccin
ie
one
vaccin
product
administr
simultan
reaction
dog
occur
day
vaccin
administ
day
occur
day
day
day
data
uk
veterinari
product
committe
report
indic
anaphylaxi
vaccin
dog
cat
vaccin
contain
larg
amount
adjuv
certain
preserv
inactiv
bacteria
proinflammatori
outer
surfac
compon
like
caus
reaction
protein
present
fetal
calf
serum
stabil
gelatin
within
vaccin
may
also
respons
allerg
reaction
banfield
studi
risk
reaction
increas
number
vaccin
dose
ie
volum
vaccin
millilit
administ
per
offic
visit
smallbre
dog
miniatur
dachshund
pug
boston
terrier
miniatur
pinscher
chihuahua
suscept
develop
acut
vaccin
reaction
risk
vaccinerel
advers
increas
bodi
weight
decreas
risk
vaccinerel
advers
event
time
greater
dog
weigh
kg
less
weigh
kg
figur
advers
event
increas
frequenc
age
year
age
dog
year
age
cat
frequenc
progress
declin
rate
lower
observ
anim
less
year
age
see
figur
decreas
frequenc
older
age
may
occur
owner
unwilling
pet
vaccin
previou
reaction
occur
sexual
intact
dog
less
like
develop
advers
reaction
neuter
dog
opposit
true
cat
femal
cat
like
exhibit
reaction
male
cat
treatment
choic
anaphylaxi
epinephrin
togeth
support
treatment
intraven
fluid
supplement
oxygen
necessari
antihistamin
corticosteroid
administ
dog
less
sever
reaction
vaccin
avoid
anim
histori
sever
reaction
pretreat
antihistamin
could
consid
anim
histori
mild
reaction
anim
also
monitor
close
hospit
sever
hour
vaccin
administr
suggest
futur
commerci
product
lowdos
vaccin
smallbre
dog
might
appropri
given
increas
risk
reaction
mark
serolog
respons
vaccin
type
ii
hypersensit
reaction
occur
igg
igm
bind
cell
surfac
antigen
fix
complement
target
cell
lysi
remov
target
cell
macrophag
within
reticuloendotheli
tissu
concern
rais
vaccin
may
predispos
certain
genet
suscept
individu
immunemedi
cytopenia
although
human
medicin
studi
dog
cat
date
fail
conclus
document
vaccin
caus
chronic
diseas
immunemedi
hemolyt
anemia
suspect
occur
follow
parvoviru
vaccin
possibl
due
hemagglutin
properti
viru
high
antigen
mass
vaccin
later
retrospect
casecontrol
studi
found
associ
transient
thrombocytopenia
occur
vaccin
dog
one
studi
dog
develop
antithyroglobulin
antibodi
vaccin
although
associ
develop
hypothyroid
cat
vaccin
crandellre
felin
kidney
crfk
cellderiv
vaccin
develop
antibodi
crfk
protein
alphaenolas
annexin
whether
product
antibodi
clinic
signific
remain
determin
type
iii
hypersensit
reaction
character
immunecomplex
deposit
tissu
may
consequ
immun
certain
vaccin
exampl
anterior
uveiti
subclin
nephriti
develop
dog
receiv
canin
vaccin
vaccin
replac
vaccin
rare
produc
lesion
cutan
vascul
describ
vaccin
dog
cat
rabi
viru
vaccin
rabi
vaccineinduc
vascul
figur
occur
site
vaccin
administr
anim
multifoc
ischem
dermatopathi
myopathi
affect
site
pinnal
margin
periocular
area
tail
tip
paw
pad
report
occur
month
appear
initi
skin
lesion
multifoc
dermatopathi
myopathi
report
resolv
treatment
pentoxifyllin
vitamin
e
addit
evid
requir
strengthen
associ
multifoc
condit
rabi
vaccin
similarli
concern
rais
possibl
tempor
associ
vaccin
immunemedi
polyarthr
dog
associ
remain
unproven
immunemedi
polyradiculoneur
type
iv
hypersensit
reaction
delayedtyp
hypersensit
occur
vaccin
dog
sucklingmous
brainderiv
inactiv
rabi
vaccin
longer
avail
subsequ
reexposur
result
sever
prolong
paralysi
granuloma
format
site
vaccin
administr
also
repres
type
iv
hypersensit
reaction
despit
lack
conclus
evid
associ
vaccin
current
avail
vaccin
autoimmun
diseas
possibl
vaccin
may
associ
dysregul
immun
respons
predispos
individu
therefor
vaccin
often
withheld
absolut
necessari
dog
cat
histori
autoimmun
diseas
serum
titer
could
also
assess
gaug
need
specif
immun
anim
diseas
occasion
result
replic
microorgan
present
vaccin
although
sever
diseas
uncommon
current
avail
vaccin
fever
lethargi
common
advers
effect
vaccin
result
cytokin
product
respons
vaccin
transient
usual
resolv
within
day
past
use
attenu
rabi
viru
vaccin
result
ascend
paralyt
diseas
proport
cat
dog
led
chang
inactiv
adjuv
rabi
vaccin
administr
attenu
parvoviru
vaccin
pregnant
cat
dog
lead
cerebellar
diseas
fetu
vaccin
potenti
caus
sever
diseas
shed
vaccin
viru
infect
colostrumdepriv
neonat
less
week
age
cdv
vaccin
associ
postvaccin
distemp
young
puppi
result
vaccin
live
attenu
cdv
cpv
dog
felin
panleukopenia
viru
cat
vaccin
avoid
pregnant
anim
puppi
kitten
less
week
age
anim
receiv
potent
anticanc
chemotherapi
drug
cdv
vaccin
strain
rockbornlik
strain
virul
other
may
continu
circul
contribut
distemp
dog
popul
safest
attenu
live
cdv
vaccin
contain
onderstepoort
strain
vaccin
certain
exot
pet
zoo
wild
anim
speci
ferret
attenu
live
cdv
vaccin
dog
also
lead
postvaccin
distemp
anim
chronic
immunocompromis
use
inactiv
vaccin
recommend
immun
deem
necessari
howev
inactiv
vaccin
may
reduc
efficaci
immunocompromis
anim
compar
healthi
anim
use
mucos
eg
intranas
vaccin
respiratori
pathogen
dog
cat
follow
develop
mild
moder
transient
upper
respiratori
tract
sign
concern
mucos
bordetella
bronchiseptica
vaccin
may
caus
respiratori
diseas
immunosuppress
human
inhal
vaccin
directli
administr
contact
vaccin
organ
subsequ
shed
vaccin
dog
definit
proof
still
requir
inadvert
parenter
administr
avirul
live
intranas
b
bronchiseptica
vaccin
dog
lead
local
injectionsit
reaction
occasion
fatal
hepat
necrosi
inadvert
parenter
administr
mucos
b
bronchiseptica
vaccin
treat
subcutan
fluid
site
administr
treatment
oral
antibiot
like
effect
b
bronchiseptica
doxycyclin
aspca
poison
control
center
also
recommend
inject
gentamicin
sulfat
solut
affect
area
mgkg
gentamicin
sulfat
ml
salin
doxycyclin
treatment
could
continu
day
dog
develop
hepat
necrosi
may
need
aggress
support
care
local
cutan
reaction
common
advers
effect
vaccin
especi
cat
includ
pain
swell
irrit
abscess
format
dog
focal
alopecia
discolor
haircoat
vaccin
site
also
occur
figur
inactiv
adjuv
vaccin
commonli
incrimin
focal
cutan
granuloma
sometim
perman
focal
alopecia
commonli
report
inactiv
rabi
vaccin
administr
breed
maltes
terrier
bichon
late
increas
inflammatori
injectionsit
reaction
site
rabi
vaccin
administr
note
canin
felin
biopsi
specimen
sent
univers
pennsylvania
shortli
thereaft
sarcoma
observ
site
cat
unit
state
increas
year
figur
follow
chang
attenu
live
inactiv
rabi
vaccin
increas
use
rabi
vaccin
cat
introduct
felv
vaccin
nation
incid
sarcoma
format
estim
sarcoma
per
cat
vaccin
contrast
unit
kingdom
per
vaccin
dose
sold
interv
tumor
develop
last
rabi
vaccin
typic
rang
month
year
tumor
fibrosarcoma
type
sarcoma
also
occur
although
develop
injectionsit
sarcoma
clearli
link
administr
felv
rabi
vaccin
develop
sarcoma
relat
use
specif
brand
type
vaccin
within
antigen
class
possibl
except
recombin
vaccin
reus
syring
needl
gaug
use
shake
multidos
vial
concomit
viral
infect
also
evid
aluminumcontain
vaccin
associ
higher
risk
sarcoma
develop
aluminumfre
vaccin
concern
adjuv
stimul
inflammatori
respons
predispos
sarcoma
format
recent
studi
show
inactiv
vaccin
approxim
time
like
associ
injectionsit
sarcoma
administ
pelvic
limb
site
nonadjuv
recombin
vaccin
howev
neither
attenu
live
recombin
inactiv
vaccin
riskfre
inject
certain
longact
inject
medic
especi
glucocorticoid
also
associ
sarcoma
format
cat
year
later
evid
administr
cold
vaccin
may
also
like
associ
sarcoma
format
requir
verif
current
hypothes
individu
cat
genet
program
wound
heal
respons
respons
develop
injectionsit
sarcoma
treatment
injectionsit
sarcoma
involv
aggress
surgic
resect
follow
fullcours
postop
radiat
therapi
high
incid
recurr
possibl
advers
effect
radiat
includ
mild
moder
cutan
burn
hypopigment
hair
field
see
figur
b
damag
spinal
cord
lung
kidney
within
field
although
last
rare
one
studi
median
surviv
time
cat
treat
postsurg
cur
radiat
therapi
month
cat
clean
margin
surgic
resect
tumor
contrast
median
surviv
time
cat
treat
coars
fraction
radiat
therapi
month
cat
gener
macroscop
diseas
dirti
margin
adjuv
chemotherapi
carboplatin
singleag
doxorubicin
also
associ
improv
outcom
order
prevent
death
sarcoma
format
cat
vaccineassoci
felin
sarcoma
task
forc
vafstf
north
america
recommend
rabi
vaccin
administ
distal
possibl
right
pelvic
limb
leukemia
vaccin
administ
distal
possibl
left
pelvic
limb
rabi
right
leukemia
left
care
taken
administ
vaccin
proxim
flank
region
tumor
locat
resect
effect
core
vaccin
administ
right
shoulder
recommend
adopt
wsava
suggest
skin
later
thorax
abdomen
use
vaccin
vaccin
site
rotat
year
year
group
recommend
interscapular
region
avoid
vaccin
constitu
pool
region
contribut
chronic
inflammatori
respons
addit
group
recommend
site
administr
product
batch
number
document
facilit
report
advers
event
excess
administr
vaccin
cat
minim
altern
rout
intranas
immun
consid
owner
advis
monitor
inject
site
month
vaccin
administ
lump
form
increas
size
month
vaccin
persist
beyond
month
owner
mass
evalu
veterinarian
accord
vafstf
recommend
anatom
locat
shape
size
mass
develop
inject
site
document
incision
trucut
biopsi
perform
fineneedl
aspir
recommend
mass
malign
routin
laboratori
test
thorac
radiographi
perform
togeth
comput
tomographi
magnet
reson
imag
mass
client
financ
allow
veterinari
oncologist
consult
possibl
referr
specialist
surgeon
oncologist
recommend
wide
excis
includ
least
margin
necessari
entir
piec
tissu
excis
submit
histopatholog
evalu
surgic
margin
addit
treatment
chemotherapi
radiat
therapi
often
necessari
cat
reevalu
interv
year
surgeri
vaccin
potenti
interfer
result
assay
detect
antibodi
respons
infect
assay
detect
compon
pathogen
interfer
antibodi
test
result
specif
nonspecif
nonspecif
interfer
rare
identifi
result
crossreact
antibodi
vaccin
compon
albumin
reagent
use
serodiagnost
test
commonli
specif
interfer
serodiagnost
test
infect
target
vaccin
occur
especi
problemat
vaccin
complet
protect
infect
result
serolog
test
requir
diagnosi
interfer
result
assay
detect
pathogen
oppos
antibodi
respons
occur
vaccin
attenu
live
vaccin
shed
anim
vaccin
exampl
cat
may
test
posit
use
elisa
assay
fpv
antigen
vaccin
attenu
live
fpv
vaccin
although
assay
rate
occur
low
pcr
test
posit
extend
period
vaccin
attenu
live
vaccin
case
sequenc
analysi
pcr
product
sometim
allow
differenti
vaccin
field
strain
current
perform
research
basi
rapid
pcr
assay
also
design
differenti
vaccin
field
strain
pathogen
cdv
b
bronchiseptica
quantif
organ
number
present
specimen
use
realtim
pcr
assay
eg
cdv
may
shed
light
whether
natur
infect
high
organ
load
vaccin
low
organ
load
occur
advantag
disadvantag
vaccin
vaccin
combin
current
avail
market
provid
relev
section
book
infect
entitl
immun
vaccin
suggest
vaccin
schedul
individu
pet
shelter
anim
base
recommend
provid
american
anim
hospit
associ
aaha
american
associ
felin
practition
aafp
european
societi
felin
medicin
esfm
wsava
summar
tabl
appendix
facilit
vaccin
select
vaccin
dog
cat
divid
variou
task
forc
core
vaccin
noncor
vaccin
gener
recommend
core
vaccin
recommend
anim
unknown
vaccin
histori
diseas
involv
signific
morbid
mortal
wide
distribut
gener
vaccin
result
good
protect
diseas
shelter
anim
vaccin
core
vaccin
entri
shelter
time
entri
immun
ahead
time
possibl
canin
core
vaccin
includ
vaccin
cpv
cdv
cav
rabi
countri
rabi
endem
core
felin
vaccin
felin
felin
caliciviru
fcv
fpv
rabi
noncor
vaccin
option
vaccin
consid
light
exposur
risk
base
geograph
distribut
lifestyl
pet
vaccin
consid
noncor
vaccin
dog
canin
parainfluenza
viru
canin
influenza
viru
b
bronchiseptica
leptospira
spp
borrelia
burgdorferi
option
noncor
vaccin
cat
includ
felv
fiv
virul
fcv
chlamydia
feli
b
bronchiseptica
vaccin
sever
vaccin
current
avail
market
dog
vaccin
canin
coronaviru
rattlesnak
envenom
report
american
veterinari
medic
associ
avma
aaha
canin
vaccin
task
forc
list
first
two
vaccin
gener
recommend
diseas
either
littl
clinic
signific
respond
readili
treatment
evid
efficaci
vaccin
minim
may
produc
advers
event
limit
benefit
current
inform
regard
efficaci
canin
rattlesnak
vaccin
insuffici
cat
felin
infecti
periton
fip
vaccin
gener
recommend
aafp
